Floatz logo

BLOOD, WHOLE

Focal Cortical Dysplasia

King's College Hospital NHS Trustother_biologicalN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Focal Cortical Dysplasia cohort.

Asset / SponsorPhaseRating
Everolimus
NYU Langone Health
Phase 2B
Radiprodil
GRIN Therapeutics, Inc.
Phase 1/2CCC
svg103
Sovargen
Phase 1/2CCC
Carbamazepine
GRIN Therapeutics, Inc.
Phase 1CC
Itraconazole
GRIN Therapeutics, Inc.
Phase 1CC

Same molecule, other indications

BLOOD, WHOLE is also rated in:

hepatic encephalopathyDormant
BB
Indicative ·
64 / 100
View asset →
cirrhosis of liverDormant
B
Indicative ·
61 / 100
View asset →
Shock HypovolemicDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →